Prevail Therapeutics Inc (PRVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,262 | -40,675 | -18,575 | -63,188 | -45,347 |
| Depreciation Amortization | 426 | 237 | 111 | 265 | 201 |
| Accounts payable and accrued liabilities | -2,565 | -3,181 | -1,219 | 3,921 | 3,711 |
| Other Working Capital | -757 | -33 | -1,414 | 2,858 | 1,174 |
| Other Operating Activity | 8,923 | 7,062 | 2,851 | 390 | -694 |
| Operating Cash Flow | $-53,235 | $-36,590 | $-18,246 | $-55,754 | $-40,955 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -544 | -374 | -287 | -2,136 | -2,050 |
| Purchase Of Investment | -32,678 | -20,130 | N/A | N/A | N/A |
| Investing Cash Flow | $-33,222 | $-20,504 | $-287 | $-2,136 | $-2,050 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 138 | 108 | 62 | 116,303 | 116,268 |
| Other Financing Activity | 0 | 0 | 0 | 46,624 | 46,797 |
| Financing Cash Flow | $138 | $108 | $62 | $162,927 | $163,065 |
| Beginning Cash Position | 168,142 | 168,142 | 168,142 | 63,105 | 63,105 |
| End Cash Position | 81,823 | 111,156 | 149,671 | 168,142 | 183,165 |
| Net Cash Flow | $-86,319 | $-56,986 | $-18,471 | $105,037 | $120,060 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,235 | -36,590 | -18,246 | -55,754 | -40,955 |
| Capital Expenditure | -544 | -374 | -287 | -2,136 | -2,050 |
| Free Cash Flow | -53,779 | -36,964 | -18,533 | -57,890 | -43,005 |